Knowthestock.com
ATRI - Atrion Corp.

Sell

Moderate Growth and StableStock Price Very High

59%

based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is 4.77%
Operating Income Growth is -7.72%
Net Income Growth is -1.56%
Earnings Per Share (EPS) Growth is -0.28%
Net Margin is 20.58%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 9.03
Debt Ratio is 0.11
Current Debt to Net Income Ratio is 0.0
Total Debt to Total Assets Ratio is 0.0
Cash Flow is MODERATE
Cash from Operations Growth is 11.4%
Capital Expenditure is Low
Net Increase in Cash is Negative
Long Term Score Trend is NEUTRAL
Investment Risk is High
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Atrion Corp. (ATRI) - www.atrioncorp.com
Atrion Corporation is a leading supplier of medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products to fluid delivery devices, are sold to end-users, distributors and other manufacturers worldwide. As a developer and manufacturer of a diverse range of products, Atrion stays on the forefront of technology and manufacturing with products that meet the needs of its targeted markets.
Exchange - NASDAQ
Industry - Surgical and Medical Instrument Manufacturing
Sector - Manufacturing
CEO -
Employees - 636
    Close


Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.